Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor (Q72119420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

Nicoletti F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Di Marco R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Barcellini W

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Schorlemmer HU

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Kurrle R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Lunetta M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Grasso S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Zaccone P

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

1843-1847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

The potentially simple mathematics of type I diabetes

24 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Sodium-lithium countertransport kinetics in normal and hypertensive human pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

The spectrum of action of new immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

The role of interleukin-1 in disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Macrophage-mediated cytotoxicity against cultured pancreatic islet cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

In vivo administration of interleukin 1 elicits increased Ia antigen expression on B cells through the induction of interleukin 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240818

7 January 2021

Identifiers

DOI

10.1002/EJI.1830240818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8056041%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference